Skip to main content
Beta Drugs Limited logo

Beta Drugs Limited — Investor Relations & Filings

Ticker · BETA ISIN · INE351Y01019 LEI · 984500A89888DB9E6T57 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2025-09-22 Regulatory Filings
Country IN India
Listing National Stock Exchange of India BETA

About Beta Drugs Limited

https://www.betadrugslimited.com

Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a brief announcement about Beta Drugs Limited receiving regulatory approval (INVIMA) for injectable and oral formulations in Colombia. It discusses market opportunities and accreditations but does not contain any financial data, detailed report content, or regulatory filings. The length is short (1503 characters), and it is an update on regulatory approval rather than a financial or management report. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is best classified as a general regulatory announcement about product approval, which fits under Regulatory Filings (RNS) as a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-09-22 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document contains multiple distinct sections including a newspaper advertisement for an Annual General Meeting (AGM) notice, a SARFAESI Act demand notice, a National Company Law Tribunal petition notice related to a composite scheme of arrangement (merger-related), a detailed notice of the 38th Annual General Meeting of Mukat Pipes Limited including remote e-voting information and book closure details, and a corrigendum to an Extraordinary General Meeting (EGM) notice related to preferential share issuance and acquisition. The largest and most detailed portion relates to the AGM notice and associated voting information for Mukat Pipes Limited, which includes the date, venue (virtual), voting instructions, and regulatory compliance references. This is a formal notice and information for an upcoming AGM, not the AGM presentation materials themselves. The document is not an Annual Report (10-K), nor an earnings release, nor a management discussion. It is not a proxy solicitation or remuneration report. The presence of multiple notices and announcements, including the AGM notice and corrigendum, suggests this is a regulatory filing or announcement document. However, the primary focus and majority content is the detailed AGM notice and voting information, which fits the category of AGM Information (AGM-R). The document is lengthy (15,000 characters) and contains the full AGM notice text, not just a brief announcement or link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the best classification is AGM Information (AGM-R).
2025-09-06 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled '20th Annual Report' and includes a detailed Notice to Shareholders for the 20th Annual General Meeting (AGM) of Beta Drugs Limited. It contains agenda items typical of an AGM notice, such as adoption of audited financial statements for the fiscal year ended March 31, 2025, appointment and reappointment of directors, ratification of auditor remuneration, and re-appointment of key managerial personnel. The document also includes procedural notes about proxies, voting, and inspection of statutory registers. The content is focused on the meeting notice and related resolutions rather than the full annual report itself. The document length is 15,000 characters, which is substantial, but the content is clearly a notice for the AGM rather than the full annual report or financial statements. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, including notices and agendas.
2025-09-05 English
Updates
AGM Information Classification · 95% confidence The document is a formal notice addressed to the National Stock Exchange of India Limited regarding the book closure dates for the purpose of the 20th Annual General Meeting (AGM) of the company Beta Drugs Ltd. It specifies the dates of book closure and the AGM schedule but does not contain any financial data, detailed reports, or voting results. The document is short (1517 characters) and serves as an announcement related to the AGM event, specifically about administrative details (book closure). It is not the AGM materials themselves, nor is it a voting result declaration. Therefore, it fits best under the category of AGM Information (AGM-R), which includes presentations and materials shared during or related to the AGM, including notices about the AGM.
2025-09-03 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a short notice informing the stock exchange about the scheduling of the 20th Annual General Meeting (AGM) of Beta Drugs Limited. It mentions that the Notice of the AGM and the Annual Report for the financial year 2024-25 will be submitted later, indicating this document itself is not the Annual Report but an announcement related to the AGM. The document length is only 1103 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), as it pertains to the AGM scheduling and related information.
2025-09-03 English
Outcome of Board Meeting
Regulatory Filings
2025-09-03 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.